Alexar Therapeutics Receives $21,500,000 Series A Financing Round

  • Feed Type
  • Date
  • Company Name
    Alexar Therapeutics
  • Mailing Address
    Undisclosed San Francicso, CA 94129
  • Company Description
    Alexar Therapeutics, Inc. is focused on developing an innovative portfolio of Liver X receptor (LXR) agonists.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    New Science Ventures
  • Venture Investor
    Third Point
  • Venture Investor
    Palo Alto Investors

By posting a comment, you agree to our terms and conditions.